Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. Mol Ther Nucleic Acids. 2013 Jul 09; 2:e105.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.